Standard treatment is CHOP. An expanded protocol, called CHOP-R, has improved survival and rates of complete responses for DFBL patients, particularly elderly patients.[3]
Prognosis
The germinal center subtype has the best prognosis, with 60% of treated patients surviving more than five years.[3]
References
^[1]Pathobiology of the aggressive and highly aggressive non-Hodgkin's lymphomas
^ Turgeon, Mary Louise (2005). Clinical hematology: theory and procedures. Hagerstown, MD: Lippincott Williams & Wilkins, 283. ISBN 0-7817-5007-5. "Frequency of lymphoid neoplasms. (Source: Modified from WHO Blue Book on Tumour of Hematopoietic and Lymphoid Tissues. 2001, p. 2001.)"
^ abc Turgeon, Mary Louise (2005). Clinical hematology: theory and procedures. Hagerstown, MD: Lippincott Williams & Wilkins, 285-286. ISBN 0-7817-5007-5.